|
IL303195A
(en)
|
2020-11-25 |
2023-07-01 |
Akagera Medicines Inc |
Lipid nanoparticles for delivery of nucleic acids and related methods of use
|
|
CA3223590A1
(en)
*
|
2021-06-14 |
2022-12-22 |
Flagship Pioneering Innovations Vi, Llc |
Modification of plant messenger packs
|
|
WO2023023055A1
(en)
|
2021-08-16 |
2023-02-23 |
Renagade Therapeutics Management Inc. |
Compositions and methods for optimizing tropism of delivery systems for rna
|
|
CN115724806B
(zh)
*
|
2021-08-25 |
2025-07-01 |
广州谷森制药有限公司 |
阳离子脂质化合物
|
|
CN118317944A
(zh)
|
2021-09-14 |
2024-07-09 |
雷纳嘉德医疗管理公司 |
非环状脂质及其使用方法
|
|
TW202328067A
(zh)
|
2021-09-14 |
2023-07-16 |
美商雷納嘉德醫療管理公司 |
環狀脂質及其使用方法
|
|
EP4408437A4
(en)
*
|
2021-10-01 |
2025-08-27 |
Univ Pennsylvania |
LIPID NANOPARTICLE (LNP) COMPOSITIONS AND METHODS OF USE THEREOF
|
|
EP4426832A1
(en)
|
2021-11-03 |
2024-09-11 |
The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone |
Precise genome editing using retrons
|
|
WO2023122752A1
(en)
|
2021-12-23 |
2023-06-29 |
Renagade Therapeutics Management Inc. |
Constrained lipids and methods of use thereof
|
|
WO2023141602A2
(en)
|
2022-01-21 |
2023-07-27 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
|
WO2023183300A1
(en)
*
|
2022-03-22 |
2023-09-28 |
The Children's Medical Center Corporation |
Compositions and methods for prevention and treatment of genetic disease
|
|
CA3255619A1
(en)
|
2022-04-07 |
2023-10-12 |
Renagade Therapeutics Management Inc. |
CYCLIC LIPIDS AND LIPID NANOPARTICLES (LPNs) FOR THE SUPPLY OF NUCLEIC ACIDS OR PEPTIDES INTENDED FOR USE IN VACCINATION AGAINST INFECTIOUS AGENTS
|
|
EP4519243A4
(en)
*
|
2022-05-04 |
2026-04-22 |
Univ Pennsylvania |
Siloxane-based lipids, lipid nanoparticle compositions comprising them, and their methods of use for targeted administration
|
|
EP4531819A2
(en)
|
2022-05-25 |
2025-04-09 |
Akagera Medicines, Inc. |
Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
|
|
JP2025525569A
(ja)
|
2022-07-18 |
2025-08-05 |
レナゲード セラピューティクス マネージメント インコーポレイテッド |
遺伝子編集成分、システム、及び使用方法
|
|
EP4561537A2
(en)
*
|
2022-07-27 |
2025-06-04 |
Trustees Of Tufts College |
Lipid nanoparticles for immunotherapy
|
|
WO2024044723A1
(en)
|
2022-08-25 |
2024-02-29 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
|
EP4680595A2
(en)
|
2023-03-15 |
2026-01-21 |
Renagade Therapeutics Management Inc. |
Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
|
|
WO2024192291A1
(en)
|
2023-03-15 |
2024-09-19 |
Renagade Therapeutics Management Inc. |
Delivery of gene editing systems and methods of use thereof
|
|
EP4680728A1
(en)
|
2023-03-17 |
2026-01-21 |
Quell Therapeutics Limited |
Treg therapy
|
|
WO2024206230A1
(en)
*
|
2023-03-24 |
2024-10-03 |
Trustees Of Tufts College |
Tissue targeting lipids and lipid nanoparticles
|
|
WO2024220609A1
(en)
*
|
2023-04-18 |
2024-10-24 |
The Trustees Of The University Of Pennsylvania |
Ionizable lipid compounds, lipid nanoparticles (lnps) comprising the same, and methods of use thereof for cell engineering
|
|
WO2025007148A1
(en)
|
2023-06-30 |
2025-01-02 |
Orna Therapeutics, Inc. |
Polymer lipid nanoparticle compositions for delivering circular polynucleotides
|
|
KR20260033596A
(ko)
*
|
2023-07-06 |
2026-03-10 |
이더알엔에이 이뮤노테라피스 엔브이 |
이온화 가능한 지질
|
|
IT202300015003A1
(it)
*
|
2023-07-18 |
2025-01-18 |
Univ Degli Studi Di Salerno |
Composizione e procedimento per la realizzazione di nano-carriers lipidici ed i relativi nano-carriers lipidici di uso biomedico
|
|
WO2025038494A1
(en)
|
2023-08-11 |
2025-02-20 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for lymphoid cell differentiation using targeted gene activation
|
|
AU2024335327A1
(en)
|
2023-09-01 |
2026-03-26 |
Renagade Therapeutics Management Inc. |
Gene editing systems, compositions, and methods for treatment of vexas syndrome
|
|
WO2025072623A1
(en)
*
|
2023-09-28 |
2025-04-03 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for targeting immune cells
|
|
WO2025075396A1
(ko)
*
|
2023-10-06 |
2025-04-10 |
한국과학기술연구원 |
타겟 핵산 검출물질이 담지된 지질 나노입자 및 이를 이용한 막융합 기반의 타겟 핵산 검출 방법
|
|
WO2025081042A1
(en)
|
2023-10-12 |
2025-04-17 |
Renagade Therapeutics Management Inc. |
Nickase-retron template-based precision editing system and methods of use
|
|
WO2025090525A1
(en)
*
|
2023-10-22 |
2025-05-01 |
Tessera Therapeutics, Inc. |
Lipid nanoparticles for delivery of therapeutic payloads to t cells
|
|
WO2025128871A2
(en)
|
2023-12-13 |
2025-06-19 |
Renagade Therapeutics Management Inc. |
Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
|
|
WO2025129333A1
(en)
*
|
2023-12-18 |
2025-06-26 |
Nanovation Therapeutics Inc. |
Lipid nanoparticles having non-polar lipids for nucleic acid delivery to the liver
|
|
WO2025144938A1
(en)
|
2023-12-26 |
2025-07-03 |
Emmune, Inc. |
Systems for nucleic acid transfer
|
|
WO2025155753A2
(en)
|
2024-01-17 |
2025-07-24 |
Renagade Therapeutics Management Inc. |
Improved gene editing system, guides, and methods
|
|
WO2025166238A1
(en)
|
2024-01-31 |
2025-08-07 |
Orna Therapeutics, Inc. |
Fast-shedding polyethylene glycol lipids
|
|
WO2025174765A1
(en)
|
2024-02-12 |
2025-08-21 |
Renagade Therapeutics Management Inc. |
Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
|
|
WO2025184476A1
(en)
*
|
2024-02-29 |
2025-09-04 |
The Trustees Of The University Of Pennsylvania |
Cationic degradable lipid compositions, lipid nanoparticles (lnps) comprising same, and methods of use thereof
|
|
WO2025252759A1
(en)
|
2024-06-03 |
2025-12-11 |
Bio-Sourcing |
Transient expression by lipid nanoparticle formulations
|
|
WO2026003582A2
(en)
|
2024-06-27 |
2026-01-02 |
Axelyf ehf. |
Lipids and lipid nanoparticles
|
|
WO2026015458A1
(en)
*
|
2024-07-08 |
2026-01-15 |
Memorial Sloan-Kettering Cancer Center |
Cells comprising non-hla restricted t cell receptors
|